Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity

[1] Symon Z(2003)Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy Int J Radiat Oncol Biol Phys 57 384-90

[2] Griffith K(2014)Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial Lancet Oncol 15 464-73

[3] McLaughlin PW(2011)70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial Int J Radiat Oncol Biol Phys 80 1056-63

[4] Sullivan M(2008)Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 67-74

[5] Sandler HM(2005)Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate JAMA 294 1233-9

[6] Dearnaley DP(2014)Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival Radiother Oncol 110 104-9

[7] Jovic G(2005)Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 1192-33

[8] Syndikus I(2008)Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes Int J Radiat Oncol Biol Phys 71 1028-80

[9] Khoo V(2012)Late toxicity rates following definitive radiotherapy for prostate cancer Can J Urol 19 6373-22

[10] Cowan R(2010)Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 14-83

[1] Symon Z(2003)Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy Int J Radiat Oncol Biol Phys 57 384-90

[2] Griffith K(2014)Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial Lancet Oncol 15 464-73

[3] McLaughlin PW(2011)70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial Int J Radiat Oncol Biol Phys 80 1056-63

[4] Sullivan M(2008)Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 67-74

[5] Sandler HM(2005)Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate JAMA 294 1233-9

[6] Dearnaley DP(2014)Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival Radiother Oncol 110 104-9

[7] Jovic G(2005)Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 1192-33

[8] Syndikus I(2008)Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes Int J Radiat Oncol Biol Phys 71 1028-80

[9] Khoo V(2012)Late toxicity rates following definitive radiotherapy for prostate cancer Can J Urol 19 6373-22

[10] Cowan R(2010)Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 14-83